Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562

T L  Holyoake; E K  Allan; J C  Mountford; L  Richmond; S J  Harrison; M A  Elliott; H G  Jorgensen

Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562

T L Holyoake, E K Allan, J C Mountford, L Richmond, S J Harrison, M A Elliott, H G Jorgensen

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Research output: Contribution to journal › Conference Contribution › peer-review

Abstract

Meeting abstract 2420 looks at pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line, K562.

Original language	English
Article number	2420
Pages (from-to)	654A-654A
Number of pages	1
Journal	Blood
Volume	102
Issue number	11
Publication status	Published - 16 Nov 2003
Event	45th Annual Meeting of the American-Society-of-Hematology - San Diego, United States Duration: 6 Dec 2003 → 9 Dec 2003

Keywords

pre-treatment
bryostatin
lonafirnib
efficacy
imatinib
G0/G1
ph+ cell line

Cite this

@article{cef53677acd545828822d2d3800fdafe,

title = "Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562",

abstract = "Meeting abstract 2420 looks at pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line, K562.",

keywords = "pre-treatment, bryostatin, lonafirnib, efficacy, imatinib , G0/G1, ph+ cell line",

author = "Holyoake, {T L} and Allan, {E K} and Mountford, {J C} and L Richmond and Harrison, {S J} and Elliott, {M A} and Jorgensen, {H G}",

year = "2003",

month = nov,

day = "16",

language = "English",

volume = "102",

pages = "654A--654A",

journal = "Blood",

issn = "0006-4971",

number = "11",

note = "45th Annual Meeting of the American-Society-of-Hematology ; Conference date: 06-12-2003 Through 09-12-2003",

}

TY - JOUR

T1 - Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562

AU - Holyoake, T L

AU - Allan, E K

AU - Mountford, J C

AU - Richmond, L

AU - Harrison, S J

AU - Elliott, M A

AU - Jorgensen, H G

PY - 2003/11/16

Y1 - 2003/11/16

N2 - Meeting abstract 2420 looks at pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line, K562.

AB - Meeting abstract 2420 looks at pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line, K562.

KW - pre-treatment

KW - bryostatin

KW - lonafirnib

KW - efficacy

KW - imatinib

KW - G0/G1

KW - ph+ cell line

M3 - Conference Contribution

SN - 0006-4971

VL - 102

SP - 654A-654A

JO - Blood

JF - Blood

IS - 11

M1 - 2420

T2 - 45th Annual Meeting of the American-Society-of-Hematology

Y2 - 6 December 2003 through 9 December 2003

ER -

Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562

Abstract

Keywords

Fingerprint

Cite this